For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development | 35,786 | 46,693* | 49,700 | 44,160 |
| General and administrative | 10,267 | 9,383* | 7,318 | 7,566 |
| Total operating expenses | 46,053 | 56,076 | 57,018 | 51,726 |
| Loss from operations | -46,053 | -56,076* | -57,018 | -51,726 |
| Interest and other income, net | 1,911 | 2,718* | 2,096 | 2,570 |
| Net loss | -44,142 | -53,358* | -54,922 | -49,156 |
| Deemed dividend on modification of common stock warrants | - | -3,714* | - | 1,857 |
| Net loss attributable to common stockholders | - | -49,644 | -54,922 | -51,013 |
| Basic EPS | -0.23 | -0.296 | -0.37 | -0.34 |
| Diluted EPS | -0.23 | -0.296 | -0.37 | -0.34 |
| Basic Average Shares | 194,200,100 | 167,872,992 | 149,123,701 | 148,320,803 |
| Diluted Average Shares | 194,200,100 | 167,872,992 | 149,123,701 | 148,320,803 |
Annexon, Inc. (ANNX)
Annexon, Inc. (ANNX)